Shang Lin to Humans
This is a "connection" page, showing publications Shang Lin has written about Humans.
Connection Strength
0.073
-
Attenuated cortisol response to alcohol in heavy social drinkers. Int J Psychophysiol. 2006 Mar; 59(3):203-9.
Score: 0.009
-
Experience of Using Telehealth for Foot and Ankle Examination During The SARS-COV-2 Crisis. Foot Ankle Spec. 2021 Oct; 14(5):453-457.
Score: 0.007
-
Effects of antidiabetic medications on cardiovascular outcomes. J Card Surg. 2020 Oct; 35(10):2759-2767.
Score: 0.006
-
COVID-19 and Oncology: Service transformation during pandemic. Cancer Med. 2020 10; 9(19):7161-7171.
Score: 0.006
-
Evaluation of microvascular density in Barrett's associated neoplasia. Mod Pathol. 2013 Jan; 26(1):125-30.
Score: 0.004
-
DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis. Cancer Res. 2010 Jul 15; 70(14):5840-50.
Score: 0.003
-
Treatment of therapy-related myeloid neoplasms with high-dose cytarabine/mitoxantrone followed by hematopoietic stem cell transplant. Leuk Lymphoma. 2010 Jun; 51(6):995-1006.
Score: 0.003
-
Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence. Leuk Lymphoma. 2009 Nov; 50(11):1809-17.
Score: 0.003
-
Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience. Am J Gastroenterol. 2009 Nov; 104(11):2684-92.
Score: 0.003
-
Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management. Gastrointest Endosc. 2009 Sep; 70(3):417-21.
Score: 0.003
-
Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer. J Thorac Oncol. 2008 Sep; 3(9):1003-11.
Score: 0.003
-
Adjuvant chemotherapy in lymph node positive bladder cancer. Urol Oncol. 2009 Mar-Apr; 27(2):160-4.
Score: 0.003
-
Development of a measure of physician engagement in addressing racial and ethnic health care disparities. Health Serv Res. 2008 Apr; 43(2):773-84.
Score: 0.003
-
Urinary and sexual function outcomes among different age groups after robot-assisted laparoscopic prostatectomy. J Endourol. 2008 Mar; 22(3):519-24.
Score: 0.003
-
Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated? Clin Gastroenterol Hepatol. 2008 Feb; 6(2):159-64.
Score: 0.003
-
Sural nerve grafting in robotic laparoscopic radical prostatectomy: interim report. J Endourol. 2007 Dec; 21(12):1547-51.
Score: 0.003
-
Prostate weight: an independent predictor for positive surgical margins during robotic-assisted laparoscopic radical prostatectomy. Can J Urol. 2007 Oct; 14(5):3697-701.
Score: 0.003
-
Predicting the risk of patients with biopsy Gleason score 6 to harbor a higher grade cancer. J Urol. 2007 Nov; 178(5):1925-8.
Score: 0.003
-
Effect of prostate weight on operative and postoperative outcomes of robotic-assisted laparoscopic prostatectomy. Urology. 2007 Feb; 69(2):300-5.
Score: 0.002
-
Phase II trial of the O6-alkylguanine DNA alkyltransferase inhibitor O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea in advanced melanoma. Clin Cancer Res. 2005 Nov 01; 11(21):7861-5.
Score: 0.002